oasis trial semaglutide Oral 25 mg Demonstrates Substantial Weight Loss in Adults with Overweight or Obesity: Results from Efficacy and safety of once-daily
Description
It should be viewed as supportive, not as a direct substitute for medical treatment
01127-3/asset/cb71a1fc-b829-4644-a5d6-f1f235f450bf/main.assets/gr2_lrg.jpg)
[1] [2] It is important to note that while Ozempic is licensed for diabetes management, a higher-dose formulation (Wegovy) is separately licensed for weight management
Benefits observed in research settings often include: Significant reduction in body weight (surpassing Semaglutide in head-to-head comparisons)
Not Sure If You Qualify
Oz called this revolutionary fat-busting drug a true game changer
It is co-formulated by Novo Nordisk and was evaluated in the phase 3 REDEFINE program [1] [6]
